This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Xofigo Banner

Xofigo® (radium-223 dichloride)

Resources

Xofigo Patient Booklet

A Guide to your Treatment with Xofigo®

Download Here

Prescribing Information of Xofigo® can be found here:

Prescribing Information
Xofigo Logo
About Xofigo®▼ (radium-223 dichloride)
Access key information about Xofigo®.
PP-XOF-IE-0127-1, January 2026
arrow_forward
Xofigo Logo
Xofigo®▼ (radium-223 dichloride) | Efficacy
Explore efficacy of Xofigo®.
PP-XOF-IE-0129-1, February 2026
arrow_forward
Xofigo Logo
Xofigo®▼ (radium-223 dichloride) | Contact Us
PP-XOF-IE-0133-1, February 2026
arrow_forward

PP-XOF-IE-0132-1   |   February 2026

 

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professional are asked to report any suspected adverse reactions.